CSF biomarkers β-amyloid, tau proteins and a-synuclein in the differential diagnosis of Parkinson-plus syndromes

The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Guy M. McKhann, David S. Knopman, Howard Chertkow et al. · Alzheimer s & Dementia · 2011 · 18.8K citations · Full text

Medicine, Geriatric Medicine, Neurology +11

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Andrew Hughes, S. E. Daniel, Linda Kilford et al. · Journal of Neurology Neurosurgery & Psychiatry · 1992 · 10.4K citations · Full text

Medicine, Neurology, Pathology +15

Second consensus statement on the diagnosis of multiple system atrophy

S. Gilman, Gregor K. Wenning, Phillip A. Low et al. · Neurology · 2008 · 3.2K citations · Full text

Medicine, Neurology, Neuroscience +7

Criteria for the diagnosis of corticobasal degeneration

Melissa J. Armstrong, Irene Litvan, Anthony E. Lang et al. · Neurology · 2013 · 1.9K citations · Full text

Medicine, Neurology, Neuroscience +15

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study

Brit Mollenhauer, Joseph J. Locascio, Walter Schulz‐Schaeffer et al. · The Lancet Neurology · 2011 · 629 citations

Life Sciences, Neurology, Neuroscience +16